Solution-Focused Therapy for Schizophrenia

The Effects of a Solution-Focused Approach on Psychosocial Adjustment and Treatment Compliance in Individuals Diagnosed With Schizophrenia

Recruiting N/A Interventional Study
SCHIZOPHRENIA 1 (Disorder) Psychosocial Adaptation Treatment Adherence
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 65
Sex
Any
Study type
Interventional
Purpose
Supportive Care
Participants needed
60 (estimated)
Sponsor
Muş Alparslan University · Other
Who this trial is looking for

This trial is looking for adults with schizophrenia who are stable and receiving regular treatment. Participants will receive a weekly therapy session for six weeks or continue with their usual care.

Are You a Good Fit for This Trial?

You may be able to join if

  • I have been diagnosed with schizophrenia
  • I am between 18 and 65 years old
  • I can read and speak clearly
  • I am clinically stable
  • I am registered with a Community Mental Health Center
  • I can participate in interviews
  • I am currently receiving psychiatric treatment
  • I agree to take part voluntarily

You may not be able to join if

  • I do not meet the inclusion criteria

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The aim of this study is to evaluate the effects of a solution-focused approach-based individual intervention on psychosocial adjustment and treatment adherence in individuals diagnosed with schizophrenia. The study will be conducted as a randomized controlled trial including 60 clinically stable individuals diagnosed with schizophrenia according to DSM-5 criteria and registered at a Community Me…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Having been diagnosed with schizophrenia according to DSM-5 diagnostic criteria, Being between 18 and 65 years of age, Being literate and verbally communicative, Being clinically stable (not exhibiting symptoms of acute psychosis), Being registered with a Community Mental …
Contacts

Fatih Şahin, dr

0534 688 1634

fatih.sahin@alparslan.edu.tr

CONTACT